Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PreVPro is a **topical nutraceutical cream** developed by Prevacus and marketed as a pre-game product intended to provide temporary relief of concussion-related inflammation when applied to the neck. Public descriptions characterize it as a smooth, non-sticky, fragrance-free, steroid-free botanical formulation containing antioxidant-rich ingredients whose components were described as Generally Regarded as Safe. Its claimed duration of effect was about six hours. The specific active ingredient composition and a validated molecular target or mechanism of action have not been clearly established in the provided material, so it is best characterized as a topical antioxidant botanical product promoted for concussion support rather than a conventional approved pharmaceutical therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PreVPro.